Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3437495rdf:typepubmed:Citationlld:pubmed
pubmed-article:3437495lifeskim:mentionsumls-concept:C0036945lld:lifeskim
pubmed-article:3437495lifeskim:mentionsumls-concept:C1265549lld:lifeskim
pubmed-article:3437495lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:3437495lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:3437495lifeskim:mentionsumls-concept:C0069761lld:lifeskim
pubmed-article:3437495pubmed:issue4lld:pubmed
pubmed-article:3437495pubmed:dateCreated1988-4-4lld:pubmed
pubmed-article:3437495pubmed:abstractTextIn goats, there was a linear correlation of area under the plasma concentration-time curve (AUC) with dose in the range 0-20 mg/kg as single dosages of oxfendazole (OFZ). The bioavailability of OFZ after oral administration was lower in goats than in sheep. The repetition of three administrations at 24 h intervals produced significant increase in the AUC in comparison with a single administration equivalent to the total dosage (1 X 5.0 and 3 X 1.7 mg/kg). Infection with O. circumcincta produced a 33% decrease in the bioavailability of OFZ.lld:pubmed
pubmed-article:3437495pubmed:languageenglld:pubmed
pubmed-article:3437495pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3437495pubmed:citationSubsetIMlld:pubmed
pubmed-article:3437495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3437495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3437495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3437495pubmed:statusMEDLINElld:pubmed
pubmed-article:3437495pubmed:monthDeclld:pubmed
pubmed-article:3437495pubmed:issn0140-7783lld:pubmed
pubmed-article:3437495pubmed:authorpubmed-author:BoganJJlld:pubmed
pubmed-article:3437495pubmed:authorpubmed-author:DelatourPPlld:pubmed
pubmed-article:3437495pubmed:authorpubmed-author:BenoitEElld:pubmed
pubmed-article:3437495pubmed:issnTypePrintlld:pubmed
pubmed-article:3437495pubmed:volume10lld:pubmed
pubmed-article:3437495pubmed:ownerNLMlld:pubmed
pubmed-article:3437495pubmed:authorsCompleteYlld:pubmed
pubmed-article:3437495pubmed:pagination305-9lld:pubmed
pubmed-article:3437495pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:meshHeadingpubmed-meshheading:3437495-...lld:pubmed
pubmed-article:3437495pubmed:year1987lld:pubmed
pubmed-article:3437495pubmed:articleTitlePharmacokinetics of oxfendazole in goats: a comparison with sheep.lld:pubmed
pubmed-article:3437495pubmed:affiliationDepartment of Veterinary Pharmacology, Veterinary School of Glasgow, U.K.lld:pubmed
pubmed-article:3437495pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3437495pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3437495pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed